Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lilin Li

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Cellular and Molecular Medicine|August 22, 2020
Urinary cMet as a prognostic marker in immunoglobulin A nephropathyJung Nam An, Lilin Li, Junghun Lee, et al.
Clinical Science (London, England : 1979)|June 1, 2021
cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7Lilin Li, Jeonghwan Lee, Ara Cho, et al.
Scientific Reports|September 19, 2019
Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosisYong Chul Kim, Junghun Lee, Jung Nam An, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Cellular and Molecular Medicine|August 22, 2020
Urinary cMet as a prognostic marker in immunoglobulin A nephropathyJung Nam An, Lilin Li, Junghun Lee, et al.
Clinical Science (London, England : 1979)|June 1, 2021
cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7Lilin Li, Jeonghwan Lee, Ara Cho, et al.
Scientific Reports|September 19, 2019
Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosisYong Chul Kim, Junghun Lee, Jung Nam An, et al.
Pageof 6